In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Coronary revascularisation: how and how much
2016 Session

Congress : ESC CONGRESS 2016

Topic : ST-Elevation Myocardial Infarction (STEMI)

  • Session type : Moderated Posters
  • Date : 29 August 2016
  • Time : 15:35 - 16:25
15 views

7 presentations in this session

2016

Routine invasive versus selective invasive strategies for non-st-elevation acute coronary syndrome: an updated meta-analysis of randomised trials

Congress : ESC Congress 2016

  • Session : Coronary revascularisation: how and how much
  • Speaker : A A Bavry (Gainesville,US)

Some member-only content

2016

Differential impact of incomplete revascularization as assessed by residual SYNTAX score on long-term mortality in patients with STEMI versus NSTEMI: a propensity-matched analysis

Congress : ESC Congress 2016

  • Session : Coronary revascularisation: how and how much
  • Speaker : D Milasinovic (Belgrade,RS)

Some member-only content

2016

Impact of staged versus one-time multivessel percutaneous ntervention in ST-elevation myocardial infarction

Congress : ESC Congress 2016

  • Session : Coronary revascularisation: how and how much
  • Speaker : M Makkiya (New York,US)

Some member-only content

2016

Transradial percutaneous coronary intervention could reduce access site complications in STEMI patients requiring intra-aortic balloon pumping support

Congress : ESC Congress 2016

  • Session : Coronary revascularisation: how and how much
  • Speaker : K Horie (Aoba-Ku,JP)

Some member-only content

2016

Transradial vs. transfemoral access in patients with ACS: bleeding complications and outcome

Congress : ESC Congress 2016

  • Session : Coronary revascularisation: how and how much
  • Speaker : J-U Roehnisch (Berlin,DE)

Some member-only content

Three reasons why you should become a member

Become a member now
  • 1Access your congress resources all year-round on the New ESC 365
  • 2Get a discount on your next congress registration
  • 3Continue your professional development with free access to educational tools
Become a member now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim, Bristol-Myers Squibb and Pfizer Alliance, and Novartis Pharma AG. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are